miR-146b-5p Enhances the Sensitivity of NSCLC to EGFR Tyrosine Kinase Inhibitors by Regulating the IRAK1/NF-κB Pathway

Although patients with non-small cell lung cancer harboring activating mutations in the epidermal growth factor receptor (EGFR) show good clinical response to EGFR tyrosine kinase inhibitors (TKIs), patients eventually develop acquired resistance. Previous studies have shown that several microRNAs (...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Mol Ther Nucleic Acids
Autori principali: Liu, Yi-Nan, Tsai, Meng-Feng, Wu, Shang-Gin, Chang, Tzu-Hua, Tsai, Tzu-Hsiu, Gow, Chien-Hung, Wang, Hsin-Yi, Shih, Jin-Yuan
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society of Gene & Cell Therapy 2020
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7554328/
https://ncbi.nlm.nih.gov/pubmed/33230450
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omtn.2020.09.015
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi